Topical becaplermin: cancer. Think twice before using it.
D000287:Administration, Topical; D017277:Drug Approval; D005602:France; D005782:Gels; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced*; D010982:Platelet-Derived Growth Factor / Q000009:adverse effects*; D014456:Ulcer / Q000188:drug therapy
D005782:Gels; D010982:Platelet-Derived Growth Factor